Humanwell Healthcare Group Co (600079.SS) Stock Price
Humanwell Healthcare Group Co Price
Revenue has compounded at 19.9% per year over the past 19 years to 23.96 B CNY. Earnings per share have grown at 12.8% per year over the last 19 years. Humanwell Healthcare Group Co's net margin stands at 7.7%, up from 6.4% several years earlier. Humanwell Healthcare Group Co currently offers a dividend yield of about 1.65%. The payout ratio is around 28% of earnings. The dividend has grown at 20.0% per year over the past 19 years. Analysts set a median price target of 23.64 CNY, implying 21.7% above the current price. Of 6 analysts, 0 rate the stock a buy — an overall Sell consensus.
Humanwell Healthcare Group Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Humanwell Healthcare Group Co business model & stock analysis
Frequently asked questions about Humanwell Healthcare Group Co
Analysts currently set an average price target of 23.64 CNY for the Humanwell Healthcare Group Co stock (median: 23.64 CNY), implying +23.1 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the Humanwell Healthcare Group Co stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect Humanwell Healthcare Group Co to generate revenue of 27.07 B CNY and earnings per share of 1.45 CNY.
Converted at the current exchange rate, the Humanwell Healthcare Group Co share trades at 2.61 EUR (19.43 CNY).
The Humanwell Healthcare Group Co share (600079.SS) is listed on 1 stock exchanges, including: Shanghai (600079.SS).
The expected revenue of Humanwell Healthcare Group Co is 27.07 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Humanwell Healthcare Group Co is 2.37 B CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Humanwell Healthcare Group Co is currently 13.40. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Humanwell Healthcare Group Co stock.
The price-to-sales ratio (P/S) of Humanwell Healthcare Group Co is currently 1.17. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Humanwell Healthcare Group Co stock.
The Eulerpool Quality Score for Humanwell Healthcare Group Co is 5/10.
The ISIN of Humanwell Healthcare Group Co is CNE000000QW6. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Humanwell Healthcare Group Co is 600079.SS. The ticker symbol is used to trade Humanwell Healthcare Group Co shares on the stock exchange.
Humanwell Healthcare Group Co stock
Humanwell Healthcare Group Co Peer Group
Humanwell Healthcare Group Co Ticker
Humanwell Healthcare Group Co FIGI
All fundamentals and in-depth analysis of Humanwell Healthcare Group Co
Our stock analysis for Humanwell Healthcare Group Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humanwell Healthcare Group Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.